Literature DB >> 19505652

Immunity to polyomavirus infection: the polyomavirus-mouse model.

Phillip A Swanson1, Aron E Lukacher, Eva Szomolanyi-Tsuda.   

Abstract

A ubiquitous clinically silent murine pathogen, polyomavirus has enjoyed long-term co-evolution with the mouse, a highly tractable and genetically and immunologically informative small animal model. Thus, polyomavirus has provided a valuable experimental construct to decipher the host immune mechanisms that come into play to control systemic low-level persistent viral infections. Impaired immunosurveillance for infected cells puts the murine host at risk both to injury resulting from excessive direct virus cytolysis and development of virus-induced tumors. In this review, we present our current understanding of the multifaceted immune response invoked by the mouse to maintain détente with this potentially deleterious persistent natural pathogen, and discuss implications of these studies for therapeutic interventions for human polyomavirus infection.

Entities:  

Mesh:

Year:  2009        PMID: 19505652      PMCID: PMC2694952          DOI: 10.1016/j.semcancer.2009.02.003

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  75 in total

1.  Promiscuous antigen presentation by the nonclassical MHC Ib Qa-2 is enabled by a shallow, hydrophobic groove and self-stabilized peptide conformation.

Authors:  X He; P Tabaczewski; J Ho; I Stroynowski; K C Garcia
Journal:  Structure       Date:  2001-12       Impact factor: 5.006

2.  Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells.

Authors:  E Szomolanyi-Tsuda; J D Brien; J E Dorgan; R L Garcea; R T Woodland; R M Welsh
Journal:  Virology       Date:  2001-02-15       Impact factor: 3.616

3.  Requirement for CD4 T cell help in generating functional CD8 T cell memory.

Authors:  Devon J Shedlock; Hao Shen
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

4.  CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses.

Authors:  Janice M Moser; James Gibbs; Peter E Jensen; Aron E Lukacher
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

5.  Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.

Authors:  Igor J Koralnik; Renaud A Du Pasquier; Marcelo J Kuroda; Jörn E Schmitz; Xin Dang; Yue Zheng; Michelle Lifton; Norman L Letvin
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

6.  Widespread expression of the nonclassical class I Qa-2 antigens in hemopoietic and nonhemopoietic cells.

Authors:  T Ungchusri; E Y Chiang; G Brown; M Chen; P Tabaczewski; L Timares; I Stroynowski
Journal:  Immunogenetics       Date:  2001-08       Impact factor: 2.846

Review 7.  Polyoma virus: old findings and new challenges.

Authors:  T L Benjamin
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

8.  Memory inflation: continuous accumulation of antiviral CD8+ T cells over time.

Authors:  Urs Karrer; Sophie Sierro; Markus Wagner; Annette Oxenius; Hartmut Hengel; Ulrich H Koszinowski; Rodney E Phillips; Paul Klenerman
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

9.  Susceptibility to polyomavirus-induced tumors in inbred mice: role of innate immune responses.

Authors:  Palanivel Velupillai; John P Carroll; Thomas L Benjamin
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Antiviral CD8+ T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells.

Authors:  J M Moser; J D Altman; A E Lukacher
Journal:  J Exp Med       Date:  2001-03-05       Impact factor: 14.307

View more
  18 in total

Review 1.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

2.  Polymorphisms in toll-like receptor 4 underlie susceptibility to tumor induction by the mouse polyomavirus.

Authors:  Palanivel Velupillai; Chang Kyoo Sung; Erik Andrews; Jennifer Moran; David Beier; Jonathan Kagan; Thomas Benjamin
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

3.  The Murine Polyomavirus MicroRNA Locus Is Required To Promote Viruria during the Acute Phase of Infection.

Authors:  James M Burke; Clovis R Bass; Rodney P Kincaid; Emin T Ulug; Christopher S Sullivan
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

4.  Gamma interferon controls mouse polyomavirus infection in vivo.

Authors:  Jarad J Wilson; Eugene Lin; Christopher D Pack; Elizabeth L Frost; Annette Hadley; Alyson I Swimm; Jun Wang; Ying Dong; Cynthia P Breeden; Daniel Kalman; Kenneth A Newell; Aron E Lukacher
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

5.  NK cells and gammadelta T cells mediate resistance to polyomavirus-induced tumors.

Authors:  Rabinarayan Mishra; Alex T Chen; Raymond M Welsh; Eva Szomolanyi-Tsuda
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

Review 6.  A cornucopia of human polyomaviruses.

Authors:  James A DeCaprio; Robert L Garcea
Journal:  Nat Rev Microbiol       Date:  2013-03-11       Impact factor: 60.633

7.  Peptide immunization elicits polyomavirus-specific MHC class ib-restricted CD8 T cells in MHC class ia allogeneic mice.

Authors:  Amelia R Hofstetter; Brian D Evavold; Aron E Lukacher
Journal:  Viral Immunol       Date:  2013-02-01       Impact factor: 2.257

8.  Inflammatory cytokine-mediated evasion of virus-induced tumors from NK cell control.

Authors:  Rabinarayan Mishra; Bojan Polic; Raymond M Welsh; Eva Szomolanyi-Tsuda
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

9.  Pathogen Stimulation History Impacts Donor-Specific CD8(+) T Cell Susceptibility to Costimulation/Integrin Blockade-Based Therapy.

Authors:  I R Badell; W H Kitchens; M E Wagener; A E Lukacher; C P Larsen; M L Ford
Journal:  Am J Transplant       Date:  2015-07-30       Impact factor: 8.086

Review 10.  NK cells and virus-related cancers.

Authors:  Rabinarayan Mishra; Raymond Welsh; Eva Szomolanyi-Tsuda
Journal:  Crit Rev Oncog       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.